Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection

BACKGROUND: Patients with inflammatory bowel disease (IBD) may be at risk for development of COVID-19 infection due to innate immune dysfunction and/or immunosuppressive medication use. METHODS: In a prospective cohort of adult IBD patients, we captured data on clinical risk factors and IBD medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Millie D, Zhang, Xian, Lewis, James D, Melmed, Gil Y, Siegel, Corey A, Cerciello, Emily, Dobes, Angela, Weaver, Alandra, Weisbein, Laura, Kappelman, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037404/
https://www.ncbi.nlm.nih.gov/pubmed/36777042
http://dx.doi.org/10.1093/crocol/otac011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037404/
https://www.ncbi.nlm.nih.gov/pubmed/36777042
http://dx.doi.org/10.1093/crocol/otac011

Ejemplares similares